Mayo Clinic RNA Discoveries and Therapeutics Conference 2025

Name: Mayo Clinic RNA Discoveries and Therapeutics Conference 2025 - Drstoree
SKU: MED-AMB04596
Price: 85.00 USD
Availability: InStock

$85.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

SKU: MED-AMB04596 Categories: Family medicine COURSES, Hematology / Oncology Tags: FAMILY MEDICINE, Oncology

Description

May 30 – 31 – 2025 – Internet Live Activity – Jacksonville, Florida

The Mayo Clinic RNA Discoveries and Therapeutics Conference 2025 will convene experts in the areas of RNA Biology and RNA Therapeutics Development and Application in disease areas including but not limited to neurological diseases, cancer and rare diseases. It will help identify gaps and opportunities in this field to leverage RNA therapeutics from discovery to translation to clinical trials.

Target Audience

This course is relevant for physicians and other healthcare providers specializing in oncology, neurology, rare diseases, and metabolic specialties. The content also benefits individuals involved in cancer research, neurological studies, the development of RNA-based therapeutics, and clinical trial coordinators.

Learning Objectives

Upon completion of this activity, participants should be able to:

Review the current state of RNA therapeutics to include their discovery and translation into practice
Assess existing approaches to the discovery of RNA targets
Identify gaps in the development of RNA therapies for common complex and rare diseases
Assess existing approaches to the development of novel therapies to include treatment and delivery modalities
Identify future opportunities for development of RNA therapies in common complex and rare diseases

FRIDAY MAY 30, 2025
7:30AM	Registration & Breakfast
8:00AM	WelcomeKent R. Thielen, M.D.
8:05AM	Mayo Clinic Research Alfredo Quinones-Hinojosa, M.D
8:10AM	Mayo Clinic RNA Program Nilüfer Ertekin-Taner, M.D., Ph.D.
8:30AM	Discovery of RNA-Targeting Compounds and Implications for Human DiseasesBlanton Tolbert, Ph.D. (University of Pennsylvania, HHMI)
9:30AM	Break/Exhibit Hall
9:45AM	Harnessing RNA Biology Towards TherapiesHaidong Dong, M.D., Ph.D. (Mayo Clinic) Jane Zhu, M.D., Ph.D. (Mayo Clinic) Jeff Coller, Ph.D. (Johns Hopkins University) Xiling Shen, Ph.D. (MD Anderson Cancer Center)
10:45AM	Short talks selected from submitted abstracts
11:45AM	Lunch/Exhibit Hall
12:45PM	Advances in Translation of RNA Therapies to the ClinicKeith Gagnon, Ph.D. (Wake Forest University School of Medicine) Julie Allickson, Ph.D. (Mayo Clinic) Keith Knutson, Ph.D. (Mayo Clinic) Robert DeLong, Ph.D. (Landmark Bio)
1:45PM	RNA Therapeutics from Bench to Bedside: Moderna Experience Patrick Finn, Ph.D. (Moderna)
2:30PM	RNA Therapeutics: From Design to ASO Candidates Jeff Milton (La Jolla Labs)
3:00PM	Break/Exhibit Hall
3:30PM	Accelerating RNA Therapies Towards the Clinic – Lessons Learned from Industry Jay Parrish, Ph.D. (Pretzel Therapeutics) Susan Catalano, Ph.D. (Circle Biopharma) Claes Wahlestedt, M.D., Ph.D. (University of Miami) Andrew J. Geall, Ph.D. (Alliance for mRNA Medicines) Kate Broderick, Ph.D. (Maravai LifeSciences) Roberta Duncan (Arcturus Therapeutics)
4:45PM	Adjourn
5:00PM – 6:30PM	Reception & Poster Exhibition

SATURDAY MAY 31, 2025
7:30AM	Breakfast
7:55AM	WelcomeNilüfer Ertekin-Taner, M.D., Ph.D. & Alfredo Quinones-Hinojosa, M.D.
8:00AM	Clinical Translation of Therapeutic RNA Nano-vaccines for CancerNatalie Silver, M.D. (Cleveland Clinic)
9:00AM	Break/Exhibit Hall
9:15AM	Applications of RNA Therapeutics and Diagnostics in Common and Rare Diseases Ken Yamada, Ph.D. (UMass Chan Medical School)Marlen Lauffer, M.D. (Dutch Center for RNA Therapeutics)Margot Cousin, Ph.D. (Mayo Clinic) Minerva Carrasquillo, Ph.D. (Mayo Clinic) Tsuneya Ikezu, M.D., Ph.D. (Mayo Clinic)
10:15AM	Short talks selected from submitted abstracts
10:45AM	Industrializing the Non-Profit ASO Treatment of Nano-Rare PatientsAmy Williford, Ph.D. (n-Lorem Foundation)
11:45AM	Lunch/Exhibit Hall
12:45PM	Argonauts and RNA TherapiesPhillip Zamore, Ph.D. (UMass Chan School of Medicine)
1:45PM	Disruption of RNA Metabolism in Neurodegeneration and Pathway to TreatmentsDon W. Cleveland, Ph.D. (University of California San Diego)
2:45PM	Break/Exhibit Hall
3:00PM	Designing RNA Therapies-Advances and Considerations in Data AnalyticsAlper Kucukural, Ph.D. (UMass Chan Medical School) Xue Wang, Ph.D. (Mayo Clinic) Yan Asmann, Ph.D. (Mayo Clinic) Richard Braatz, Ph.D. (MIT)
4:00PM	Closing Remarks/Adjourn